Session Information

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer in Singapore


    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1597

    All times listed are in Singapore time (GMT+8)

    PL - Plenary
    PS - Presidential Symposium
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    IS - Industry Symposium
    JICC - Joint IASLC-CAALC-CSCO Session

Filter Results:

Show Only CME Accredited Sessions

  • +

    P29 - Palliative and Supportive Care - Clinical Trial in Progress

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Palliative and Supportive Care
    • +

      P29.01 - Therapeutic Thoracentesis vs Iodopovidone Pleurodesis in Malignant Pleural Effusion Secondary to Lung Cancer–Randomizedtrial

      00:00 - 00:00  |  Presenting Author(s): Satya Mantha Padmaja

      • Abstract

      Loading...

    • +

      P29.02 - TIP: Romiplostim for Chemo-Induced Thrombocytopenia in Adults with Solid Tumors; A P3 Randomized Placebo-Controlled Double-Blind Studies

      00:00 - 00:00  |  Presenting Author(s): Armando Armas

      • Abstract

      Loading...

  • +

    P30 - Palliative and Supportive Care

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Palliative and Supportive Care
    • +

      P30.01 - Machine Learning can be used to Predict need to see a Dietitian in Patients with Advanced Lung Cancer.

      00:00 - 00:00  |  Presenting Author(s): iain Phillips

      • Abstract

      Loading...

    • +

      P30.02 - Assessing SIADH (Syndrome of Inapproriate Antidiuretic Hormone Secretion) Management and Outcome Among Lung Cancer Patients: The Assert Trial

      00:00 - 00:00  |  Presenting Author(s): Rossana Berardi

      • Abstract

      Loading...

    • +

      P30.03 - A Simple Solution to Screening for Dietetic Need in Patients with Advanced Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): iain Phillips

      • Abstract

      Loading...

    • +

      P30.04 - The Value of Clinical and Genetic Factors in Pain Management in EGFR Mutated Advanced Lung Adenocarcinoma Patients

      00:00 - 00:00  |  Presenting Author(s): Milena Cavic

      • Abstract

      Loading...

    • +

      P30.05 - Perception of Palliative Care and Prognostic Awareness of Lung Cancer Treatment in an Oncogene-Driven Lung Cancer Community

      00:00 - 00:00  |  Presenting Author(s): Ivy Beth Elkins

      • Abstract

      Loading...

    • +

      P30.06 - Outcome Differences Amongst Histopathological Variants of Non Small Cell Lung Cancer Treated With Palliative Radiotherapy

      00:00 - 00:00  |  Presenting Author(s): Abhirup Chanda

      • Abstract

      Loading...

    • +

      P30.07 - Can Response to Chemotherapy Be a Surrogate of Response to Immunotherapy in Second and Subsequent Lines- Real World Data

      00:00 - 00:00  |  Presenting Author(s): Ewa Celina Chmielowska

      • Abstract

      Loading...

    • +

      P30.08 - The Evaluation of Fatigue in Malignant Pleural Effusion

      00:00 - 00:00  |  Presenting Author(s): Avinash Aujayeb

      • Abstract

      Loading...

    • +

      P30.09 - Exposure to Antibiotics May Affect Progression-Free Survival Negatively in NSCLC Patients Receiving First-Line Chemotherapy

      00:00 - 00:00  |  Presenting Author(s): xiaoman Tian

      • Abstract

      Loading...

    • +

      P30.10 - Local Pulmonary Administration of Tranexamic Acid as Inhalational or Nebulized for the Control of Hemoptysis: A Systematic Review of Case Reports, Case Series, and an RCT

      00:00 - 00:00  |  Presenting Author(s): Lawrence Cyril Gaudiel Vitug

      • Abstract

      Loading...

    • +

      P30.11 - Psychosocial Requirements in Lung Cancer Care

      00:00 - 00:00  |  Presenting Author(s): Csaba Laszlo Degi

      • Abstract

      Loading...

    • +

      P30.12 - The Impact of Pacemaker and Methylprednisolone Pulse Therapy on Immune-Related Myocarditis With Complete Atrioventricular Block

      00:00 - 00:00  |  Presenting Author(s): Fang Wu

      • Abstract

      Loading...

    • +

      P30.13 - The Effect of Anlotinib Instead of Glucocorticoids for Encephaledema Induced by Brain Metastases in NSCLC Patients With Anti-PD1/PDL1 Therapy

      00:00 - 00:00  |  Presenting Author(s): Hongqing Zhuang

      • Abstract

      Loading...

  • +

    P31 - Palliative and Supportive Care - Case Report

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Palliative and Supportive Care
    • +

      P31.01 - A False Alarm of COVID-19 Pneumonia in Lung Cancer: A Case Report of Anti-PD-1 Related Pneumonitis

      00:00 - 00:00  |  Presenting Author(s): Ying Dai

      • Abstract

      Loading...

  • +

    P32 - Palliative and Supportive Care - Misc. Topics

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Palliative and Supportive Care
    • +

      P32.01 - Effect of Refined Nursing on Postoperative Early Ambulation in Patients with Thoracoscopic Surgery for Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): heling Zhou

      • Abstract

      Loading...

    • +

      P32.02 - Cohort Study of Rehabilitation Quality in Patients With U-VATS and M-VATS Lobectomy

      00:00 - 00:00  |  Presenting Author(s): Xiaoqin Liu

      • Abstract

      Loading...

    • +

      P32.03 - Comparison of Two Nursing Effects in Patients With NSCLC Within 2 Hours After General Anesthesia

      00:00 - 00:00  |  Presenting Author(s): Yuanyong Wang

      • Abstract

      Loading...

    • +

      P32.04 - Preoperative Self-Reported Symptom Burden and Quality of Life of Patients Undergoing Lung Cancer Surgery: A Cross-Sectional Study

      00:00 - 00:00  |  Presenting Author(s): Wei Dai

      • Abstract

      Loading...

    • +

      P32.05 - Correlation Between Malnutrition Universal Screen Tool Score and Outcomes Following Surgical Treatment of Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Tomoyo Fujiwara

      • Abstract

      Loading...

    • +

      P32.06 - Investigation of the Current Use of Opioid Analgesics After Lung Resection and the Analysis of Its Influencing Factors

      00:00 - 00:00  |  Presenting Author(s): yuanqiang Zhang

      • Abstract

      Loading...

    • +

      P32.07 - Shortness of Breath in Patients After Thoracomy: A Pilot Study

      00:00 - 00:00  |  Presenting Author(s): Guangqiang Shao

      • Abstract

      Loading...

    • +

      P32.08 - Chest Pain After Thoracomy: A Prospective Pilot Study

      00:00 - 00:00  |  Presenting Author(s): Guangqiang Shao

      • Abstract

      Loading...

  • +

    P33 - Pathology - Immunotherapy Biomarker

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      P33.01 - Circulating Extracellular Vesicles as Biomarkers for Immune-Checkpoint Inhibitors in Advanced NSCLC

      00:00 - 00:00  |  Presenting Author(s): Diego Signorelli

      • Abstract

      Loading...

    • +

      P33.02 - Comparison of PD-L1 Protein Expression Between Primary and Metastatic Lesions in Lung Cancer Patients

      00:00 - 00:00  |  Presenting Author(s): Myrto Moutafi

      • Abstract

      Loading...

    • +

      P33.03 - Alteration of Circulating Blood Lymphocyte Subtypes Reveal Therapy Effect in Non-small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): LIANGLIANG XU

      • Abstract

      Loading...

    • +

      P33.04 - Programmed Death-Ligand 1 (PD-L1) Changes in Non-Small-Cell Lung Cancer (NSCLC): Clinical, Pathologic, and Genomic Correlates

      00:00 - 00:00  |  Presenting Author(s): Stephanie L. Alden

      • Abstract

      Loading...

    • +

      P33.05 - Identifying Biomarkers of Immune Signature Related to Smoking and Overall Survival in NSCLC on Gene Co-Expression Network

      00:00 - 00:00  |  Presenting Author(s): Kunsong Li

      • Abstract

      Loading...

    • +

      P33.06 - Utilizing Serum Proteome to Understand Response and Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Won Kyung Hur

      • Abstract

      Loading...

    • +

      P33.07 - Peripheral CD4+ T cell Signatures in Predicting Response to Anti-PD-1 Monotherapy for Chinese Advanced Non-Small Cell Lung Cancer Patients

      00:00 - 00:00  |  Presenting Author(s): Ying Wang

      • Abstract

      Loading...

    • +

      P33.08 - Granulocyte Colony-Stimulating Factor-Producing Lung Cancer With Highly Expresses PD-L1 Protein Expression Level.

      00:00 - 00:00  |  Presenting Author(s): Kazuhito Miyazaki

      • Abstract

      Loading...

    • +

      P33.09 - Tumor Mutational Burden in Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy: Outcomes in a Multiethnic Cohort

      00:00 - 00:00  |  Presenting Author(s): Laura Sofia Munoz-Arcos

      • Abstract

      Loading...

    • +

      P33.10 - Identification of Long-Responders and Fast-Progressors under Immunotherapy Based on Early Monitoring of dNLR in Advanced NSCLC Patients

      00:00 - 00:00  |  Presenting Author(s): Mariona Riudavets

      • Abstract

      Loading...

    • +

      P33.11 - Immunotherapy Outcomes in KRAS Mutated vs KRAS Wild-Type Advanced Lung Adenocarcinoma

      00:00 - 00:00  |  Presenting Author(s): Danielle Collons

      • Abstract

      Loading...

    • +

      P33.12 - Real-World Prevalence of PD-L1 Expression in Chinese Patients with Advanced or Metastatic NSCLC: Express II Study

      00:00 - 00:00  |  Presenting Author(s): Dong-Mei Lin

      • Abstract

      Loading...

    • +

      P33.13 - Prognostic and Predictive Value of Complete Blood Count Parameters in Patients with NSCLC Treated with PD-1 Inhibitors

      00:00 - 00:00  |  Presenting Author(s): Ioannis Tourkantonis

      • Abstract

      Loading...

    • +

      P33.14 - STK11/LKB1, KRAS Mutations and Immune-Related Adverse Events as Predictors of Response to Immunotherapy in Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Luis E. Raez

      • Abstract

      Loading...

    • +

      P33.15 - TMB in the First-Line Setting of NSCLC: A Systematic Review with Indirect Comparisons Between PD-1 and PD-L1 Inhibitors

      00:00 - 00:00  |  Presenting Author(s): VALERIO Gristina

      • Abstract

      Loading...

    • +

      P33.16 - Relationship Between PD-L1 Expression and FDG-PET Imaging in Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Ken Onodera

      • Abstract

      Loading...

    • +

      P33.17 - Incidence of PD-L1 Expression at Clinically Significant Cut Offs in NSCLC EGFR Mutated Population Compared to Wild Type

      00:00 - 00:00  |  Presenting Author(s): Barbara Melosky

      • Abstract

      Loading...

    • +

      P33.18 - The Prevalence of PDL-1 Expression in Lung Cancer: Real-World Experience from a Tertiary Care Oncology Centre

      00:00 - 00:00  |  Presenting Author(s): Rajiv Kumar

      • Abstract

      Loading...

    • +

      P33.19 - Association Between Expression of Immune Response-Related Genes and Response to Nivolumab in Metastatic Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Augusto Obuti Saito

      • Abstract

      Loading...

    • +

      P33.20 - Evaluation of Combined Biomarker of Response to Immunotherapy in Patients with Advanced Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Hayat Oum El Kheir Ramdani

      • Abstract

      Loading...

    • +

      P33.21 - Epidemiological Characteristics and Survival in Patients With Lung Cancer in a Peruvian Private Institution Between 2011-2014

      00:00 - 00:00  |  Presenting Author(s): Jose Maria Gutierrez

      • Abstract

      Loading...

    • +

      P33.23 - Tumor Infiltrating Immune Cells Predict Clinical Outcome after Immune Checkpoint Inhibitor Therapy in NSCLC 

      00:00 - 00:00  |  Presenting Author(s): Guojie Lu

      • Abstract

      Loading...

  • +

    P34 - Pathology - Liquid Biopsy

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      P34.01 - Utility of Assessment of the EGFR Resistance Genotype using Cell-Free DNA and CTCs from Liquid Biopsies  

      00:00 - 00:00  |  Presenting Author(s): Martin P Barr

      • Abstract

      Loading...

    • +

      P34.02 - Detection of PD-L1 Expression and Its Clinical Significance in Circulating Tumor Cells From Patients With Non-Small-Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Yuxin Cheng

      • Abstract

      Loading...

    • +

      P34.03 - A ‘Plasma-First’ Molecular Profiling Approach Complements Actionable Mutation Detection in Suspected Lung Cancer Patients

      00:00 - 00:00  |  Presenting Author(s): Jamie Mong

      • Abstract

      Loading...

    • +

      P34.04 - Circulating Tumor DNA (ctDNA) as a Marker of Progressive Disease in Patients with Advanced Lung Cancer 

      00:00 - 00:00  |  Presenting Author(s): Bryan C Ulrich

      • Abstract

      Loading...

    • +

      P34.05 - Perioperative Driver Mutation Detection in Circulating Tumor DNA from Lung Cancer Patients across Multiple Timepoints

      00:00 - 00:00  |  Presenting Author(s): Yue Pu

      • Abstract

      Loading...

    • +

      P34.06 - The Clinical Utility of Liquid Biopsy by Digital Droplet PCR in Patients with Advanced NSCLC

      00:00 - 00:00  |  Presenting Author(s): Virginie Jeanine Lamberts

      • Abstract

      Loading...

    • +

      P34.07 - Quantification of BIM mRNA In Circulating Tumor Cells Of Osimertinib-treated Patients with EGFR Mutation-positive Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Kazutoshi Isobe

      • Abstract

      Loading...

    • +

      P34.08 - Circulating Tumor Cell as a Predictive Marker for Immunotherapy in Advanced Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Cheol-Kyu Park

      • Abstract

      Loading...

    • +

      P34.09 - The Dynamic Changes of ctDNA and cfDNA in the Perioperative Period of Early NSCLC have the Potential to Predict the Risk of Recurrence

      00:00 - 00:00  |  Presenting Author(s): Zheng Ma

      • Abstract

      Loading...

    • +

      P34.10 - Transformation to Small Cell Lung Cancer from an Adenocarcionma EGFR+ as Resistance Mechanism. Utility of Liquid Biopsy in Treatment Selection

      00:00 - 00:00  |  Presenting Author(s): Miguel Muñoz

      • Abstract

      Loading...

  • +

    P35 - Pathology - Genomics

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      P35.01 - Genomic Origin and Immune-related Status of Pulmonary Sarcomatoid Carcinoma

      00:00 - 00:00  |  Presenting Author(s): Likun Chen

      • Abstract

      Loading...

    • +

      P35.02 - Lung Adenocarcinoma with Oncogenic SMARCA4 Mutation: Possible Target of Cancer Immunotherapy

      00:00 - 00:00  |  Presenting Author(s): Hee Sang Hwang

      • Abstract

      Loading...

    • +

      P35.03 - Methylation Signatures Associated with T790M Status in Progressive NSCLC

      00:00 - 00:00  |  Presenting Author(s): Grainne O'Kane

      • Abstract

      Loading...

    • +

      P35.04 - The Prognostic Value of Metastasis to Different Organs in EGFR-Mutated Stage IV NSCLC Patients Treated with First-Line Icotinib

      00:00 - 00:00  |  Presenting Author(s): Yudong Wang

      • Abstract

      Loading...

    • +

      P35.05 - The Monitoring of Mutated EGFR Levels in Liquid Biopsy from Patients on EGFR-TKIs – Early Detection of NSCLC Progression

      00:00 - 00:00  |  Presenting Author(s): Joanna Chorostowska-Wynimko

      • Abstract

      Loading...

    • +

      P35.06 - The Biomarkers of Radiation Pneumonia in NSCLC Were Based on Serum Proteomic Changes

      00:00 - 00:00  |  Presenting Author(s): jiancheng Li

      • Abstract

      Loading...

    • +

      P35.07 - Analysis of Inter-Tumor Heterogeneity Among Lesions in Autopsy Cases With Untreated Lung Cancer by DNA Methylation Profiling

      00:00 - 00:00  |  Presenting Author(s): Hiroaki Harada

      • Abstract

      Loading...

    • +

      P35.08 - RNA-Based Gene Alteration and Expression Analysis in Sq-NSCLC with known FGFR1 Amplification and Protein Expression Status

      00:00 - 00:00  |  Presenting Author(s): Joanna Chorostowska-Wynimko

      • Abstract

      Loading...

    • +

      P35.09 - Oncogenetic Differences in Never-Smokers versus Smokers with NSCLC Adenocarcinoma Treated at the Mt Sinai Tisch Cancer Institute

      00:00 - 00:00  |  Presenting Author(s): Philip Christopher Mack

      • Abstract

      Loading...

    • +

      P35.10 - Concomitant Driver Gene Mutations in Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Jianping Wang

      • Abstract

      Loading...

    • +

      P35.11 - Molecular Profiling Can Distinguish Multiple Lung Primary Tumors From Intrapulmonary Metastases

      00:00 - 00:00  |  Presenting Author(s): Wei Cheng

      • Abstract

      Loading...

    • +

      P35.12 - Assessment of Molecular Heterogeneity in Multiple Primary Lung Cancer Patients by Whole-Exome Sequencing

      00:00 - 00:00  |  Presenting Author(s): Lizhu Lin

      • Abstract

      Loading...

    • +

      P35.14 - NGS-Based Molecular Profiling of ‘Quadruple-Negative’ (EGFR/KRAS/ALK/ROS1) Advanced Non-Small-Cell Lung Cancer (aNSCLC).

      00:00 - 00:00  |  Presenting Author(s): Sara Pilotto

      • Abstract

      Loading...

    • +

      P35.15 - Molecular Epidemiology of KRAS G12C Mutations in Chinese Lung Cancer Patients

      00:00 - 00:00  |  Presenting Author(s): Herbert H Loong

      • Abstract

      Loading...

    • +

      P35.16 - Biomarker Landscape in Multicenter China Lung Cancer Precision Medicine Registry

      00:00 - 00:00  |  Presenting Author(s): Jinbo Wu

      • Abstract

      Loading...

    • +

      P35.17 - Novel Genetic Characteristics in Low-Grade Fetal Adenocarcinoma of the Lung

      00:00 - 00:00  |  Presenting Author(s): Shuyang Zhang

      • Abstract

      Loading...

    • +

      P35.18 - Genomic Alteration Profiles in Rare Types of Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Jirapath Wiwitkeyoonwong

      • Abstract

      Loading...

    • +

      P35.19 - The Mutational Landscape in South Asian Patients with Non-Small Cell Lung Cancer at an US Academic Medical Center

      00:00 - 00:00  |  Presenting Author(s): Mohana Roy

      • Abstract

      Loading...

    • +

      P35.20 - Genomic Profiling and PD-L1 Expression Association Analysis in Epstein-Barr Virus (EBV)-infected Lung Cancer Patients

      00:00 - 00:00  |  Presenting Author(s): Xiahui Yang

      • Abstract

      Loading...

    • +

      P35.21 - Comprehensive Genomic Profiling of Lung Metastases in Cancer Patients

      00:00 - 00:00  |  Presenting Author(s): Li Wang

      • Abstract

      Loading...

    • +

      P35.23 - Integrated Analysis of Genomic and Immunological Features in Lung Adenocarcinoma with Micropapillary Component

      00:00 - 00:00  |  Presenting Author(s): Yang Xu

      • Abstract

      Loading...

    • +

      P35.24 - Evaluation of an Up-To-Date Knowledge Base to Aid in Interpreting Somatic Mutations Detected in NGS Testing of Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Stephanie J. Yaung

      • Abstract

      Loading...

    • +

      P35.26 - Comparative Genomic Profiling of Lung Adenocarcinoma in Self-Reported Asian and White Patients, a Propensity Matched Study of 1400 Samples

      00:00 - 00:00  |  Presenting Author(s): Jian Zhou

      • Abstract

      Loading...

    • +

      P35.27 - Next Generation Sequencing Reveals the Genetic Landscape of JAK Family in Chinese Lung Cancer Patients

      00:00 - 00:00  |  Presenting Author(s): Lin Gui

      • Abstract

      Loading...

    • +

      P35.29 - The Genomic Landscape of Lung Cancer Patients Highlights Age-Dependent Mutation Frequencies and Clinical Actionability in Young Patients

      00:00 - 00:00  |  Presenting Author(s): Xiaoling Tong

      • Abstract

      Loading...

  • +

    P36 - Pathology - Prognosis

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      P36.01 - KEAP1 and NRF2 Mutations in Hispanic and Non-Hispanic Patients with NSCLC: Clinicopathologic Characteristics and Prognosis.

      00:00 - 00:00  |  Presenting Author(s): Khadeja Khan

      • Abstract

      Loading...

    • +

      P36.02 - CHEK1: Unfavourable Prognostic Hub Gene and Potential Therapeutic Target for Lung Adenocarcinoma

      00:00 - 00:00  |  Presenting Author(s): 谭 Tan

      • Abstract

      Loading...

    • +

      P36.03 - Identification of Immune-Related lncRNA Clusters and Prognostic Effects for Lung Adenocarcinoma Patients

      00:00 - 00:00  |  Presenting Author(s): Haiyong Wang

      • Abstract

      Loading...

    • +

      P36.04 - Molecular Prognostic Factors in Neuroendocrine Thymic Tumors: a Retrospective Multicentre Study

      00:00 - 00:00  |  Presenting Author(s): Niccolò Daddi

      • Abstract

      Loading...

    • +

      P36.05 - Metastatic NSCLC Outcomes With Guideline-Recommended Treatment By KRAS Subtype

      00:00 - 00:00  |  Presenting Author(s): Anifat Elegbede

      • Abstract

      Loading...

    • +

      P36.06 - The Association Between Prognostic Value and Mutations in TGF-β Signaling Pathway in Small Cell Lung Cancer Patients

      00:00 - 00:00  |  Presenting Author(s): Qing Bu

      • Abstract

      Loading...

    • +

      P36.07 - Pleckstrin Homology-Like (PHLDA) Domain Family Members Immunoexpression as Prognostic Marker in Lung Cancer and Mesothelioma

      00:00 - 00:00  |  Presenting Author(s): Camila Machado Baldavira

      • Abstract

      Loading...

    • +

      P36.08 - Effect of Soluble CD39 and PD-L1 Levels on Diagnosis and Prognosis of Lung Cancer Patients with Malignant Pleural Effusion

      00:00 - 00:00  |  Presenting Author(s): Tangfeng Lv

      • Abstract

      Loading...

    • +

      P36.09 - Overexpression of KIAA0101 Promotes the Progression of Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): He Cao

      • Abstract

      Loading...

    • +

      P36.10 - Prognostic Value and Transcriptional Expression Profile of GINS Family Members in Lung Adenocarcinoma

      00:00 - 00:00  |  Presenting Author(s): Fangyan Zhong

      • Abstract

      Loading...

    • +

      P36.11 - Clinicopathological Features of Long-Term Survivors in Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Ioannis Tourkantonis

      • Abstract

      Loading...

  • +

    P37 - Pathology - Biomarker Testing

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      P37.01 - Detection of NTRK Rearrangements by Next-Generation Sequencing in Chinese Lung Carcinoma Patients

      00:00 - 00:00  |  Presenting Author(s): Ming Wu

      • Abstract

      Loading...

    • +

      P37.02 - Identification of Gene Fusions and Mutations in Patients with NSCLC using two Diagnostic Approaches: Rapid qPCR and NGS

      00:00 - 00:00  |  Presenting Author(s): Andrzej Tysarowski

      • Abstract

      Loading...

    • +

      P37.03 - Analysis of Drug-Induced RNA Expression Changes in NSCLC Patient-Derived Explants as a Potential Tool for Personalized Therapy Choice

      00:00 - 00:00  |  Presenting Author(s): Evgeny Imyanitov

      • Abstract

      Loading...

    • +

      P37.04 - EGFR Mutations in US Hispanics with Lung Adenocarcinoma are Common and Portend a Worse Prognosis

      00:00 - 00:00  |  Presenting Author(s): Jonathan Villena-Vargas

      • Abstract

      Loading...

    • +

      P37.05 - Prognostic Characteristics and Immunotherapy Response of Non-Squamous NSCLC Patients with KRAS Mutation in East Asian Populations

      00:00 - 00:00  |  Presenting Author(s): Shang-Gin Wu

      • Abstract

      Loading...

    • +

      P37.06 - Are all ALK Gene Rearrangements Created Equal??

      00:00 - 00:00  |  Presenting Author(s): Ullas Batra

      • Abstract

      Loading...

    • +

      P37.07 - Discordance on Repeat PD-L1 Testing in Non-Small Cell Lung Carcinoma

      00:00 - 00:00  |  Presenting Author(s): Julia R Naso

      • Abstract

      Loading...

    • +

      P37.08 - OncomineTM Dx Target Test Companion Diagnostic System for Advanced Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Fumiyoshi Ohyanagi

      • Abstract

      Loading...

    • +

      P37.09 - Comparison of 3 Different Methods for Determination of EGFR p.Thr790Met mutation in patients with NSCLC

      00:00 - 00:00  |  Presenting Author(s): Andrzej Tysarowski

      • Abstract

      Loading...

    • +

      P37.10 - PD-L1 Expression in Lymphovascular Tumor Emboli in Lung Adenocarcinoma

      00:00 - 00:00  |  Presenting Author(s): Yi-Chen Yeh

      • Abstract

      Loading...

    • +

      P37.11 - Assessment of Plasma D-Dimer as a Predictive Biomarker for Treatment Response in Lung Cancer Treated with Radiation Therapy

      00:00 - 00:00  |  Presenting Author(s): Abhirup Chanda

      • Abstract

      Loading...

    • +

      P37.12 - Concordance of Next-Generation Sequencing Between Tissue and Liquid Biopsies in Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Fahmin Basher

      • Abstract

      Loading...

    • +

      P37.13 - Diagnostic Performance of Aptamer-Based Multiplex PCR Compared to Luminex Assay for Detection of Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Yunha Nam

      • Abstract

      Loading...

    • +

      P37.14 - Comparative Evaluation of IHC versus FISH for Detection of ROS1 Fusion in Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Rajiv Kumar

      • Abstract

      Loading...

    • +

      P37.15 - Prevalence of Targetable Mutations using a RT-qPCR Multiplex Assay in Asian NSCLC Patients: A Single Laboratory Experience

      00:00 - 00:00  |  Presenting Author(s): Shi Feng Nyaw

      • Abstract

      Loading...

    • +

      P37.16 - Alterations in HRR Related Genes as Potential Markers of Clinical Benefit from PARP Inhibitor and PD-1/PD-L1 Blockade in Advanced Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): yu Lei

      • Abstract

      Loading...

    • +

      P37.17 - Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutations in Non-small Cell Lung Cancer (NSCLC): A Global Meta-analysis

      00:00 - 00:00  |  Presenting Author(s): Barbara Melosky

      • Abstract

      Loading...

    • +

      P37.18 - Lung NSCLC Molecular Diagnostic Comparison Between NGS and Multiplex PCR Assays

      00:00 - 00:00  |  Presenting Author(s): Kiat Hon Tony Lim

      • Abstract

      Loading...

    • +

      P37.19 - Activin-A and GDF-11 as Predictive Biomarkers for Platinum Response in Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Jennifer Wen Ying Lim

      • Abstract

      Loading...

    • +

      P37.20 - Diagnostic EGFR Mutations in Non Small Cell Lung Cancer With Specimens of Body Cavity Fluids

      00:00 - 00:00  |  Presenting Author(s): Nguyen Son Lam

      • Abstract

      Loading...

    • +

      P37.21 - Improvement of PCR-Based Detection of ALK Rearrangements

      00:00 - 00:00  |  Presenting Author(s): Evgeny Imyanitov

      • Abstract

      Loading...

    • +

      P37.22 - Unique Characterization of KRAS Mutation in Non-Small Cell Lung Cancer in Thai Population

      00:00 - 00:00  |  Presenting Author(s): Narumol Trachu

      • Abstract

      Loading...

    • +

      P37.23 - Real-World PD-L1 Expression in Lung Cancer and its Correlation with Driver Mutations

      00:00 - 00:00  |  Presenting Author(s): Tao Wang

      • Abstract

      Loading...

    • +

      P37.24 - Identification of microRNAs in Non-Small-Cell Lung Cancer Based on Bioinformation Analysis

      00:00 - 00:00  |  Presenting Author(s): lulu Feng

      • Abstract

      Loading...

    • +

      P37.25 - Clinical Validation of Low-costs Next Generation Sequencing Panels in Solid Tumors

      00:00 - 00:00  |  Presenting Author(s): Yen-Lin Chen

      • Abstract

      Loading...

    • +

      P37.26 - Comprehensive Comparison of 22C3 and SP263 PD-L1 Expression using Routine Clinical and Conditioned Archives of Non-Small-Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Tae Jung Kim

      • Abstract

      Loading...

    • +

      P37.27 - Epidemiology of EGFR Positive Adenocarcinoma NSCLC From India: A Systematic Review and Meta-analysis

      00:00 - 00:00

      • Abstract

      Loading...

    • +

      P37.29 - Clinical Characteristics that Affect the Success Rate of BRAF-V600E Oncomine Dx Target Test

      00:00 - 00:00  |  Presenting Author(s): Yuki Sato

      • Abstract

      Loading...

    • +

      P37.30 - Prevalence of Actionable Mutations among Indian Patients with Advanced Non-Small Cell Lung Cancer: A Systematic Review

      00:00 - 00:00  |  Presenting Author(s): Ruchir Raman

      • Abstract

      Loading...

    • +

      P37.31 - Trends in the Detection of EGFR Exon 20 Insertions in Patients with NSCLC in the US

      00:00 - 00:00  |  Presenting Author(s): Huamao M Lin

      • Abstract

      Loading...

    • +

      P37.32 - Epigenetic Imprinted Genes as Biomarkers for the Proactive Detection and Accurate Presurgical Diagnosis of Small Lung Nodules

      00:00 - 00:00  |  Presenting Author(s): Ning Zhou

      • Abstract

      Loading...

    • +

      P37.33 - A look at EGFR, ALK, and PD-L1 Biomarker Test Availability, Adoption, and Test Ordering Behavior at Diagnosis of NSCLC in the United States

      00:00 - 00:00  |  Presenting Author(s): Jirawas Sornkom

      • Abstract

      Loading...

    • +

      P37.34 - Outcome Associations with p16, GATA-3, and TTF-1 Clone SP141 IHC Expression in Resected Stage I Lung Squamous Cell Carcinomas

      00:00 - 00:00  |  Presenting Author(s): Artem Shevtsov

      • Abstract

      Loading...

    • +

      P37.35 - Identification of DNA Methylation Markers to Distinguish Early-Stage Lung Adenocarcinomas from Benign Pulmonary Nodules

      00:00 - 00:00  |  Presenting Author(s): Feilong Zhao

      • Abstract

      Loading...

  • +

    P38 - Pathology - Pathology/Staging

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      P38.01 - The Role of Pathology in The Proposed Subdivided N Descriptors of The TNM Staging System For Lung Cancer– A Single Center Experience

      00:00 - 00:00  |  Presenting Author(s): Pınar Bulutay

      • Abstract

      Loading...

    • +

      P38.02 - Reproducibility and Accuracy of Intra-Operative Assessment on Tumor Spread Through Air Spaces in Stage 1 Lung Adenocarcinomas

      00:00 - 00:00  |  Presenting Author(s): Julian A. Villalba

      • Abstract

      Loading...

    • +

      P38.03 - Immunohistochemical, Histologic and Genomic Characterisation of Early Stage Pulmonary Invasive Mucinous Adenocarcinoma

      00:00 - 00:00  |  Presenting Author(s): Aaron C Tan

      • Abstract

      Loading...

    • +

      P38.04 - 3D Analysis of Spread Through Air Spaces in Squamous Cell Carcinoma and Carcinoid Tumor Using Whole Block Imaging by Micro CT

      00:00 - 00:00  |  Presenting Author(s): Takashi Inoue

      • Abstract

      Loading...

    • +

      P38.05 - Clinical, Genetic, Radiological, and Pathological Characteristics of Cribriform Adenocarcinoma of the Lung

      00:00 - 00:00  |  Presenting Author(s): Akihiko Yoshizawa

      • Abstract

      Loading...

    • +

      P38.06 - Evaluation of Non-invasive Transcutaneous Bioconductance Measurement - a Risk-Stratification Biomarker for Suspicious Pulmonary Lesions

      00:00 - 00:00  |  Presenting Author(s): Dawei Yang

      • Abstract

      Loading...

    • +

      P38.07 - Comprehensive Investigation of Mutational Features of Various Lung Adenocarcinoma Histological Subtypes Among Chinese Patients

      00:00 - 00:00  |  Presenting Author(s): Yuchen Han

      • Abstract

      Loading...

    • +

      P38.08 - Clinical Features and Survival Risk Factors of Lung Lymphoepithelioma-Like Carcinoma Based on the SEER Database Analysis

      00:00 - 00:00  |  Presenting Author(s): Chun-wei Xu

      • Abstract

      Loading...

    • +

      P38.09 - Clinicopathological Characteristics of Combined Small-Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Yuko Iida

      • Abstract

      Loading...

    • +

      P38.10 - Relationship Between the Diffusing Capacity of the Lung for Carbon Monoxide (DLCO) and Lung Adenocarcinoma Patterns: A Single-Center Experience

      00:00 - 00:00  |  Presenting Author(s): Luigi Ventura

      • Abstract

      Loading...

    • +

      P38.11 - Clinical and Molecular Characteristics of TSC1/2 Mutant Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Yanye Wang

      • Abstract

      Loading...

    • +

      P38.12 - Lung Adenocarcinoma with Sarcomatoid Transformation after Tyrosine Kinase Inhibitor Treatment and Chemotherapy

      00:00 - 00:00

      • Abstract

      Loading...

    • +

      P38.13 - Cytology-Histology Concordance for Diagnosis, Histological Subtyping and Molecular Profiling of Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Ioannis Tourkantonis

      • Abstract

      Loading...

    • +

      P38.14 - Demographic and Molecular Epidemiologic Profile of Primary Lung Cancer in Eastern India

      00:00 - 00:00  |  Presenting Author(s): Satya Mantha Padmaja

      • Abstract

      Loading...

    • +

      P38.15 - Interactive Genes Between Tumor Immune Microenvironment and Epithelial-Mesenchymal Transition During Lung Cancer Metastasis

      00:00 - 00:00  |  Presenting Author(s): Jie Ma

      • Abstract

      Loading...

    • +

      P38.16 - Expression of ROS1 Gene Rearrangement in Pulmonary Inflammatory Myofibroblastic Tumor With Cerebral Metastasis: Case Report  

      00:00 - 00:00  |  Presenting Author(s): IHSAN Alloubi

      • Abstract

      Loading...

    • +

      P38.17 - Pulmonary Small Cell Carcinoma with Rhabdomyoblastic Differentiation: A Previously Unreported Occurrence

      00:00 - 00:00  |  Presenting Author(s): Jasper Johar

      • Abstract

      Loading...

    • +

      P38.18 - A Rare Case of Pleomorphic Carcinoma Arising in Adulthood Type 1 Congenital Pulmonary Airway Malformation

      00:00 - 00:00  |  Presenting Author(s): Niccolò Daddi

      • Abstract

      Loading...

    • +

      P38.19 - Lung Cancer in Young Adults: A Two-Center, Retrospective Study of the Clinical and Pathological Characteristics

      00:00 - 00:00  |  Presenting Author(s): Mora Guardamagna

      • Abstract

      Loading...